Mereo BioPharma Group plc Share Price London S.E.
Equities
MPH
GB00BZ4G2K23
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% | -10.17% | -.--% |
Sales 2024 * | 27.5M 34.44M 2.75B | Sales 2025 * | 12.5M 15.65M 1.25B | Capitalization | 366M 458M 36.59B |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.02M -800M | Net income 2025 * | -28M -35.07M -2.8B | EV / Sales 2024 * | 8.63 x |
Net cash position 2024 * | 128M 161M 12.85B | Net cash position 2025 * | 142M 178M 14.21B | EV / Sales 2025 * | 17.9 x |
P/E ratio 2024 * |
-348
x | P/E ratio 2025 * |
-70.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.94% |
Managers | Title | Age | Since |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 28/02/15 |
Founder | 64 | 09/07/15 | |
Charles Sermon
FOU | Founder | 55 | 28/02/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 22/04/19 |
Director/Board Member | - | 09/11/22 | |
Director/Board Member | 59 | 22/04/19 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- MREO Stock
- MPH Stock